Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2014 Dec 5:77:14-7.
doi: 10.1016/j.curtheres.2014.11.001. eCollection 2015 Dec.

Ciprofloxacin-Induced Antibacterial Activity Is Attenuated by Phosphodiesterase Inhibitors

Majed M Masadeh  1 , Karem H Alzoubi  2 , Omar F Khabour  3 , Sayer I Al-Azzam  2
Affiliations

Ciprofloxacin-Induced Antibacterial Activity Is Attenuated by Phosphodiesterase Inhibitors

Majed M Masadeh et al. Curr Ther Res Clin Exp. .

Abstract

Background: Ciprofloxacin is a commonly used antibiotic for urinary tract infection that interacts with bacterial topoisomerases leading to oxidative radicals generation and bacterial cell death. Phosphodiesterase inhibitors (PDEis), on the other hand, are commonly used drugs for the management of erectile dysfunction. The group includes agents such as sildenafil, vardenafil, and tadalafil.

Objectives: We investigated whether PDEi could interfere with the antibacterial activity of ciprofloxacin.

Methods: PDEis were tested in several reference bacteria, including Escherichia coli, Staphylococcus aureus, Pseudomonas aeruginosa, Staphylococcus epidermidis, Acinetobacter baumannii, Proteus mirabilis, and Klebsiella pneumoniae utilizing a standard disc diffusion method and measuring both zones of inhibition and MIC.

Results: Results from both assays indicated that ciprofloxacin demonstrates potent activity against the tested reference bacteria. Additionally, when bacteria were treated with a combination of ciprofloxacin and sildenafil, tadalafil, or vardenafil, the zones of the combination inhibition were significantly reduced, whereas the MIC values were significantly greater than those of ciprofloxacin alone for all tested bacterial strains. In an attempt to examine the mechanism by which PDEis interfere with the action of ciprofloxacin, we utilized the in vitro E coli DNA gyrase cleavage assay. The results showed that PDEi drugs had no effect on ciprofloxacin's inhibition of E coli gyrase activity.

Conclusions: Pretreatment of various reference bacterial cells with PDEis largely inhibited the antibacterial activity of ciprofloxacin.

Keywords: MIC; PDEi; antimicrobial susceptibility; ciprofloxacin; sildenafil; tadalafil; vardenafil.

PubMed Disclaimer

Figures

Figure 1
Figure 1
The Escherichia coli DNA gyrase cleavage assay. DNA gyrase was incubated with supercoiled pBR322 in the presence of 0.1 µg/ML ciprofloxacin (CFX) and/or 1 of the phosphodiesterase inhibitors (100 µM). Bands were separated using 1% agarose and visualized using ethidium bromide. Phosphodiesterase inhibitors (100 µM) did not affect antigyrase activity of 0.1 µg/mL CFX.
See this image and copyright information in PMC

References

    1. Lombardi G., Nelli F., Celso M., Mencarini M., Del Popolo G. Treating erectile dysfunction and central neurological diseases with oral phosphodiesterase type 5 inhibitors. Review of the literature. J Sex Med. 2012;9:970–985. - PubMed
    1. Smith W.B., 2nd, McCaslin I.R., Gokce A., Mandava S.H., Trost L., Hellstrom W.J. PDE5 inhibitors: considerations for preference and long-term adherence. Int J Clin Pract. 2013;67:768–780. - PubMed
    1. Patel D.N., Li L., Kee C.L., Ge X., Low M.Y., Koh H.L. Screening of synthetic PDE-5 inhibitors and their analogues as adulterants: analytical techniques and challenges. J Pharm Biomed Anal. 2014;87:176–190. - PubMed
    1. Guzman D.C., Olguin H.J., Brizuela N.O., Garcia E.H., Mejia G.B., Jacobo A.J., Abarca L.S., Betancourt E.T. Effect of prostaglandin E1 (PGE1) and sildenafil on serotonin metabolism and some oxidative damage markers in rat prostate gland and brain. Andrologia. 2011;43:266–272. - PubMed
    1. Puerta E., Barros-Minones L., Hervias I., Gomez-Rodriguez V., Orejana L., Pizarro N., de la Torre R., Jordan J., Aguirre N. Long-lasting neuroprotective effect of sildenafil against 3,4-methylenedioxymethamphetamine- induced 5-hydroxytryptamine deficits in the rat brain. J Neurosci Res. 2012;90:518–528. - PubMed

LinkOut - more resources